Abstract
Since 1985, ketamine, a frequently used human and veterinary anaesthetic, has been listed as an essential medicine by the World Health Organization. This N-methyl-d-aspartate receptor antagonist has also been used and studied extensively for its role in the treatment of depression. Owing to its potential implications on health when used illicitly, at least 60 countries have already put ketamine under national control. Its illicit use has been reported on a global scale, so are its delirious complications from chronic abuse. The detrimental effects of ketamine abuse encompass different organ systems, where long-lasting complications on the genitourinary, gastrointestinal, hepatobiliary and neuropsychiatric systems stood out. In this relatively new entity of ketamine-associated complications, the importance of proper assessment and building of good rapport is emphasized. Abstinence is the first key for the successful management of its complications. Both medical and surgical management have its role in the multidisciplinary management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Absalan F, Ghannadi A, Zabihi A (2014) The effects of different doses of ketamine on quality of normal ejaculated sperm. Int J Fertil Steril 8(2):207–214
Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S, Tse JM, Lau FL, Yiu MK, Man CW (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102(11):1616–1622. https://doi.org/10.1111/j.1464-410X.2008.07920.x
Dinis-Oliveira RJ (2017) Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci Res 2(1):2–10. https://doi.org/10.1080/20961790.2017.1285219
Home Office (U.K.) NS (2018) Drug misuse: findings from the 2017/18 Crime Survey for England and Wales. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/729249/drug-misuse-2018-hosb1418.pdf. Accessed 11 Jun 2019
Hong YL, Yee CH, Tam YH, Wong JH, Lai PT, Ng CF (2018) Management of complications of ketamine abuse: 10 years’ experience in Hong Kong. Hong Kong Med J 24(2):175–181. https://doi.org/10.12809/hkmj177086
Huang LK, Wang JH, Shen SH, Lin AT, Chang CY (2014) Evaluation of the extent of ketamine-induced uropathy: the role of CT urography. Postgrad Med J 90(1062):185–190. https://doi.org/10.1136/postgradmedj-2013-131776
Jang MY, Long CY, Chuang SM, Huang CH, Lin HY, Wu WJ, Juan YS (2012) Sexual dysfunction in women with ketamine cystitis: a case-control study. BJU Int 110(3):427–431. https://doi.org/10.1111/j.1464-410X.2011.10780.x
Jhang JF, Hsu YH, Jiang YH, Lee CL, Kuo HC (2018) Histopathological characteristics of ketamine-associated uropathy and their clinical association. NeurourolUrodyn 37(5):1764–1772. https://doi.org/10.1002/nau.23514
Liu SYW, Ng SKK, Tam YH, Yee SCH, Lai FPT, Hong CYL, Chiu PWY, Ng EKW, Ng CF (2017) Clinical pattern and prevalence of upper gastrointestinal toxicity in patients abusing ketamine. J Dig Dis 18(9):504–510. https://doi.org/10.1111/1751-2980.12512
Mak SK, Chan MT, Bower WF, Yip SK, Hou SS, Wu BB, Man CY (2011) Lower urinary tract changes in young adults using ketamine. J Urol 186(2):610–614. https://doi.org/10.1016/j.juro.2011.03.108
Mason K, Cottrell AM, Corrigan AG, Gillatt DA, Mitchelmore AE (2010) Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol 65(10):795–800. https://doi.org/10.1016/j.crad.2010.05.003
Narcotics Division SBTGotHKSAR (2019) Central Registry of drug abuse sixty-seventh report 2008-2017 (Chapter 2). https://www.nd.gov.hk/pdf/report/crda_67th/Chapter2%20Trends%20(67th).pdf. Accessed 20 May 2019
Ng CM, Ma WK, To KC, Yiu MK (2012) The Chinese version of the pelvic pain and urgency/frequency symptom scale: a useful assessment tool for street-ketamine abusers with lower urinary tract symptoms. Hong Kong Med J 18(2):123–130
Ng CF, Chiu PK, Li ML, Man CW, Hou SS, Chan ES, Chu PS (2013) Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures. Int Urol Nephrol 45(5):1245–1251. https://doi.org/10.1007/s11255-013-0501-4
Seto WK, Mak SK, Chiu K, Vardhanabhuti V, Wong HF, Leong HT, Lee PSF, Ho YC, Lee CK, Cheung KS, Yuen MF, Leung WK (2018) Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users. J Hepatol 69(1):121–128. https://doi.org/10.1016/j.jhep.2018.03.006
Shahani R, Streutker C, Dickson B, Stewart RJ (2007) Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69(5):810–812. https://doi.org/10.1016/j.urology.2007.01.038
Sihra N, Ockrim J, Wood D (2018) The effects of recreational ketamine cystitis on urinary tract reconstruction—a surgical challenge. BJU Int 121(3):458–465. https://doi.org/10.1111/bju.14094
Song M, Yu HY, Chun JY, Shin DM, Song SH, Choo MS, Song YS (2016) The fibrosis of ketamine, a noncompetitive N-methyl-D-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model. Drug Chem Toxicol 39(2):206–212. https://doi.org/10.3109/01480545.2015.1079916
Tam YH, Ng CF, Pang KK, Yee CH, Chu WC, Leung VY, Wong GL, Wong VW, Chan HL, Lai PB (2014) One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients’ characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adults. BJU Int 114(5):754–760. https://doi.org/10.1111/bju.12675
Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM (2012) The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int 110(11):1762–1766. https://doi.org/10.1111/j.1464-410X.2012.11028.x
Yang SS, Jang MY, Lee KH, Hsu WT, Chen YC, Chen WS, Chang SJ (2018) Sexual and bladder dysfunction in male ketamine abusers: a large-scale questionnaire study. PLoS One 13(11):e0207927. https://doi.org/10.1371/journal.pone.0207927
Yee CH, Lai PT, Lee WM, Tam YH, Ng CF (2015) Clinical outcome of a prospective case series of patients with ketamine cystitis who underwent standardized treatment protocol. Urology 86(2):236–243. https://doi.org/10.1016/j.urology.2015.05.003
Yee CH, Teoh JY, Lai PT, Leung VY, Chu WC, Lee WM, Tam YH, Ng CF (2017) The risk of upper urinary tract involvement in patients with ketamine-associated uropathy. Int Neurourol J 21(2):128–132. https://doi.org/10.5213/inj.1732704.352
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yuen, S.K.K., Ng, A.C.F. (2020). Management of Complications of Ketamine Abuse. In: Hashimoto, K., Ide, S., Ikeda, K. (eds) Ketamine. Springer, Singapore. https://doi.org/10.1007/978-981-15-2902-3_3
Download citation
DOI: https://doi.org/10.1007/978-981-15-2902-3_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2901-6
Online ISBN: 978-981-15-2902-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)